LOUIS BUSCAIL,GERARD TIRABY,FABIENNE VERNEJOUL,CHRISTIANE SUSINI,DANIEL DROCOURT
申请号：
US14588585
公开号：
US20150190480A1
申请日:
2015.01.02
申请国别(地区):
US
年份:
2015
代理人:
摘要：
The present invention concerns products containing (i) at least one nucleic acid sequence coding for the human somatostatin 2 receptor protein (sst2) having the sequence SEQ ID NO: 1, ortholog or derivative thereof, (ii) at least one nucleic acid sequence coding for the human deoxycytidine kinase protein (dck) having the sequence SEQ ID NO:2, ortholog or derivative thereof, (iii) at least one nucleic acid sequence coding for the human uridine monophosphate kinase protein (umk) having the sequence SEQ ID NO: 3 ortholog or derivative thereof, and (iv) gemcitabine, as a combined preparation for simultaneous, separate, or sequential use for treating cancer in a subject.
